| 序号 | 产品名称 | 产品数量 |
| 1 | 1071654-84-6 | 1 |
| 2 | Disuccinimidyl Sulfoxide | 1 |
| 3 | 1351828-03-9 | 1 |
| 4 | Prostaglandin E2 Ethanolamide MaxSpec? Standard | 1 |
| 5 | (-)-Sparteine((-)-Lupinidine) | 1 |
| 6 | Hexylene glycol(2-Methyl-2,4-pentanediol) | 1 |
| 7 | β-Amyloid 1-28(Amyloidβ-Protein(1-28)) | 1 |
| 8 | Dulaglutide(LY2189265) | 1 |
| 9 | CAM-IN-1 | 1 |
| 10 | Tazanolast(TO 188) | 1 |
| 11 | Paroxypropione(4'-Hydroxypropiophenone) | 1 |
| 12 | Bromindione(Fluidane) | 1 |
| 13 | Carvedilol metabolite 4-Hydroxyphenyl Carvedilol(4-Hydroxyphenyl Carvedilol) | 1 |
| 14 | Proinsulin C-Peptide(55-89),human | 1 |
| 15 | 11097-48-6 | 1 |
| 16 | D15 | 1 |
| 17 | 251939-41-0 | 1 |
| 18 | (±)-threo-3-Methylglutamic acid | 1 |
| 19 | 2-(4-Hydroxyphenylazo)benzoic acid | 1 |
| 20 | 15-deoxy-&Delta-12,14-Prostaglandin J2 | 1 |
| 21 | HX 630 | 1 |
| 22 | 188844-52-2 | 1 |
| 23 | (2'S)-Nicotine-1-oxide | 1 |
| 24 | 4-Vinylbenzoic Acid | 1 |
| 25 | UR-144 Degradant N-pentanoic acid metabolite | 1 |
| 26 | 1630022-97-7 | 1 |
| 27 | 2C-N(exempt preparation) | 1 |
| 28 | RCS-4 N-(4-hydroxypentyl)metabolite | 1 |
| 29 | 1448893-03-5 | 1 |
| 30 | (±)19(20)-EpDTE | 1 |
| 31 | methyl 2-Pyrimidine Carboxylate | 1 |
| 32 | 34253-03-7 | 1 |
| 33 | 25B-NBOH(hydrochloride) | 1 |
| 34 | 1539266-16-4 | 1 |
| 35 | 5(Z),8(Z),11(Z)-Eicosatrienoic Acid methyl ester | 1 |
| 36 | 14602-39-2 | 1 |
| 37 | JWH 250 N-pentanoic acid metabolite | 1 |
| 38 | 1379604-65-5 | 1 |
| 39 | MRS2179(ammonium salt) | 1 |
| 40 | 228264-19-5 | 1 |
| 41 | &gamma-GT | 1 |
| 42 | β-Amyloid 22-35(Amyloidβ-Protein(22-35)) | 1 |
| 43 | PH-064(BIM-46187) | 1 |
| 44 | BNP-45 rat(Brain natriuretic peptide-45 rat) | 1 |
| 45 | L-Eflornithine(L-DFMO) | 1 |
| 46 | BCIP(BCIP p-toluidine salt) | 1 |
| 47 | Apronal(Allylisopropylacetylurea) | 1 |
| 48 | N3PT | 1 |
| 49 | Nicotinic acid mononucleotide | 1 |
| 50 | 321-02-8 | 1 |
| 51 | P110&delta-IN-1 | 1 |
| 52 | 236392-56-6 | 1 |
| 53 | Peroxy Orange 1 | 1 |
| 54 | 1199576-10-7 | 1 |
| 55 | NNEI 2'-naphthyl isomer | 1 |
| 56 | 1338925-12-4 | 1 |
| 57 | JWH 081 N-(5-hydroxypentyl)metabolite | 1 |
| 58 | 1427325-66-3 | 1 |
| 59 | (±)11(12)-EET | 1 |
| 60 | 8(Z)-Eicosenoic Acid | 1 |
| 61 | 76261-96-6 | 1 |
| 62 | (±)12-HpETE | 1 |
| 63 | (±)-2-Methyl Arachidonoyl-2'-Fluoroethylamide | 1 |
| 64 | (R)-(-)-JWH 018 N-(4-hydroxypentyl)metabolite | 1 |
| 65 | 1454924-71-0 | 1 |
| 66 | 2-(4-Fluorophenyl)piperazine | 1 |
| 67 | 65709-33-3 | 1 |
| 68 | 3,4',5-Trismethoxybenzophenone | 1 |
| 69 | 4-(Neopentyloxysulfonyl)phenylboronic Acid | 1 |
| 70 | 957060-74-1 | 1 |
| 71 | 4-Pyrimidinecarboxaldehyde,dimethyl acetal | 1 |
| 72 | 25746-87-6 | 1 |
| 73 | &delta14-Triamcinolone acetonide | 1 |
| 74 | ACTH 1-17(α1-17-ACTH) | 1 |
| 75 | Retinol(Vitamin A1) | 1 |
| 76 | TA-7552 | 1 |
| 77 | 104756-72-1 | 1 |
| 78 | GCN2-IN-1(A-92) | 1 |
| 79 | Antitumor Compound 2 | 1 |
| 80 | Afegostat D-Tartrate(D-Isofagomine(D-Tartrate)) | 1 |
| 81 | Ivabradine metabolite N-Demethyl Ivabradine hydrochloride(N-Demethyl ivabradine hydrochloride) | 1 |
| 82 | β-CGRP,human(Humanβ-CGRP) | 1 |
| 83 | Etofylline(7-(β-Hydroxyethyl)theophylline) | 1 |
| 84 | 6-O-Apiosyl-5-O-Methylvisammioside | 1 |
| 85 | 2296727-52-9 | 1 |
| 86 | Mastoparan X | 1 |
| 87 | 72093-22-2 | 1 |
| 88 | β-CCB | 1 |
| 89 | 254753-54-3 | 1 |
| 90 | 105637-38-5 | 1 |
| 91 | 2-(4-Oxoquinazolin-3(4H)-yl)acetic acid | 1 |
| 92 | (-)-CP 47,497 | 1 |
| 93 | 1,2-Dilinoleoyl-3-Stearoyl-rac-glycerol | 1 |
| 94 | 2190-17-2 | 1 |
| 95 | 2-hydroxy Decanoic Acid methyl ester | 1 |
| 96 | 71271-24-4 | 1 |
| 97 | 3-hydroxy Undecanoic Acid methyl ester | 1 |
| 98 | 129758-71-0 | 1 |
| 99 | 1,2,3-Tri-12(Z)-Heneicosanoyl-rac-glycerol | 1 |
| 100 | 169054-26-6 | 1 |
m.cnreagent.com